USA: Grinspoon criticizes "pharmaceuticalization" In an article for the Boston Globe

Source: Boston Globe
August 17, 2003

Dr. Lester Grinspoon criticizes the "pharmaceuticalization" of cannabis and concludes: "Even if pharmaceutical companies invest the many millions of dollars it will take to develop useful cannabinoid products, they will not displace natural marijuana for most purposes. And because the primary, and for many the only, advantage of these drugs will be legality, their manufacturers will have an interest in vigorously enforced prohibition that raises the price of the competitive product, street marijuana.” Dr. Grinspoon is an emeritus professor of psychiatry at Harvard Medical School and author of "Marijuana, the Forbidden Medicine."